Sofia Doulkeridou

564 total citations
9 papers, 251 citations indexed

About

Sofia Doulkeridou is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Sofia Doulkeridou has authored 9 papers receiving a total of 251 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Oncology. Recurrent topics in Sofia Doulkeridou's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Glycosylation and Glycoproteins Research (3 papers) and Nanoparticle-Based Drug Delivery (2 papers). Sofia Doulkeridou is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Glycosylation and Glycoproteins Research (3 papers) and Nanoparticle-Based Drug Delivery (2 papers). Sofia Doulkeridou collaborates with scholars based in Netherlands, United States and Denmark. Sofia Doulkeridou's co-authors include Sabrina Oliveira, Cornelus F. van Nostrum, Raymond M. Schiffelers, Javier Sastre Toraño, Wim E. Hennink, Paul M.P. van Bergen en Henegouwen, Katerina T. Xenaki, Bram Dorresteijn, B.J.C. Janssen and Wout Oosterheert and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Controlled Release and Structure.

In The Last Decade

Sofia Doulkeridou

9 papers receiving 247 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofia Doulkeridou Netherlands 7 149 83 61 50 43 9 251
Antonella Grigoletto Italy 13 198 1.3× 91 1.1× 83 1.4× 63 1.3× 81 1.9× 31 414
Jürgen Siekmann Austria 8 120 0.8× 50 0.6× 45 0.7× 35 0.7× 12 0.3× 18 305
Rita Sala Spain 11 230 1.5× 66 0.8× 76 1.2× 34 0.7× 79 1.8× 15 371
Amber Downes Ireland 4 278 1.9× 48 0.6× 72 1.2× 78 1.6× 48 1.1× 7 465
Martin A. Leon United States 9 170 1.1× 87 1.0× 23 0.4× 27 0.5× 33 0.8× 11 381
Mariangela Spitali United Kingdom 4 212 1.4× 145 1.7× 49 0.8× 32 0.6× 44 1.0× 10 331
Homam Albaghdadi Canada 6 100 0.7× 106 1.3× 61 1.0× 56 1.1× 31 0.7× 6 256
Otto K. Kari Finland 7 165 1.1× 34 0.4× 105 1.7× 101 2.0× 37 0.9× 9 331
Toshiaki Tagawa Japan 9 250 1.7× 97 1.2× 181 3.0× 72 1.4× 40 0.9× 12 386

Countries citing papers authored by Sofia Doulkeridou

Since Specialization
Citations

This map shows the geographic impact of Sofia Doulkeridou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Doulkeridou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Doulkeridou more than expected).

Fields of papers citing papers by Sofia Doulkeridou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia Doulkeridou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Doulkeridou. The network helps show where Sofia Doulkeridou may publish in the future.

Co-authorship network of co-authors of Sofia Doulkeridou

This figure shows the co-authorship network connecting the top 25 collaborators of Sofia Doulkeridou. A scholar is included among the top collaborators of Sofia Doulkeridou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofia Doulkeridou. Sofia Doulkeridou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Bagchi, Atrish, Steven E. Stayrook, Katerina T. Xenaki, et al.. (2024). Structural insights into the role and targeting of EGFRvIII. Structure. 32(9). 1367–1380.e6. 3 indexed citations
2.
Doulkeridou, Sofia, et al.. (2022). Structural insights into the non-inhibitory mechanism of the anti-EGFR EgB4 nanobody. BMC Molecular and Cell Biology. 23(1). 12–12. 11 indexed citations
3.
Su, Ruifang, Sofia Doulkeridou, Xue Qiu, et al.. (2022). A Nanobody‐on‐Quantum Dot Displacement Assay for Rapid and Sensitive Quantification of the Epidermal Growth Factor Receptor (EGFR). Angewandte Chemie International Edition. 61(33). e202207797–e202207797. 16 indexed citations
4.
Su, Ruifang, Sofia Doulkeridou, Xue Qiu, et al.. (2022). A Nanobody‐on‐Quantum Dot Displacement Assay for Rapid and Sensitive Quantification of the Epidermal Growth Factor Receptor (EGFR). Angewandte Chemie. 134(33). 1 indexed citations
5.
Lith, Sanne A. M. van, Gerben M. Franssen, Bianca A.W. Hoeben, et al.. (2022). Novel VHH-Based Tracers with Variable Plasma Half-Lives for Imaging of CAIX-Expressing Hypoxic Tumor Cells. Molecular Pharmaceutics. 19(10). 3511–3520. 10 indexed citations
7.
Oosterheert, Wout, Katerina T. Xenaki, Wouter Pos, et al.. (2020). Implications for tetraspanin-enriched microdomain assembly based on structures of CD9 with EWI-F. Life Science Alliance. 3(11). e202000883–e202000883. 23 indexed citations
8.
Doulkeridou, Sofia, Raymond M. Schiffelers, Javier Sastre Toraño, et al.. (2018). Insights into maleimide-thiol conjugation chemistry: Conditions for efficient surface functionalization of nanoparticles for receptor targeting. Journal of Controlled Release. 282. 101–109. 125 indexed citations
9.
Doulkeridou, Sofia. (2013). Middle East Respiratory Syndrome coronavirus (MERS-CoV): A Review. Utrecht University Repository (Utrecht University). 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026